Angle Will Reshape Liquid Diagnostics By Capturing Circulating Tumor Cells

Following a successful fundraise, Angle is poised to further commercialize its proprietary cell-catching technology for cancer diagnosis

• Source: Angle PLC

More from In Vitro Diagnostics

More from Diagnostics